Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Revenue (2016 - 2025)

Jaguar Health (JAGX) has disclosed Revenue for 11 consecutive years, with $3.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Revenue fell 0.8% to $3.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $11.8 million, a 50.26% increase, with the full-year FY2024 number at $11.7 million, up 19.75% from a year prior.
  • Revenue was $3.1 million for Q3 2025 at Jaguar Health, up from $3.0 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $3.5 million in Q4 2024 to a low of $6000.0 in Q2 2021.
  • A 5-year average of $2.3 million and a median of $2.6 million in 2022 define the central range for Revenue.
  • Peak YoY movement for Revenue: tumbled 99.81% in 2021, then surged 48583.33% in 2022.
  • Jaguar Health's Revenue stood at $2.1 million in 2021, then surged by 57.55% to $3.3 million in 2022, then fell by 29.81% to $2.3 million in 2023, then surged by 52.57% to $3.5 million in 2024, then dropped by 12.14% to $3.1 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Revenue are $3.1 million (Q3 2025), $3.0 million (Q2 2025), and $2.2 million (Q1 2025).